Literature DB >> 9330190

Asthma mortality in Latin America.

H Neffen1, C E Baena-Cagnani, S Malka, D Solé, R Sepúlveda, L Caraballo, E Caravajal, R Rodríguez Gavaldá, S González Díaz, J Guggiari Chase, C Díez, J Baluga, A Capriles Hulett.   

Abstract

There are not enough data concerning asthma mortality in Latin America. The Latin American Society of Allergy and Immunology coordinated this project to provide reliable data for gaining knowledge about our present situation, which is a condition indispensable to changing it. The following countries participated in this study: Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Mexico, Paraguay, Peru, Uruguay and Venezuela. A uniform protocol was designed in Santa Fe, Argentina. Asthma mortality rates were analyzed in accordance with two variables: age-adjusted rates (5-34) and total death rates. The total population studied was 107, 122, 529 inhabitants. The highest death rates were found in Uruguay and Mexico (5.63), and the lowest in Paraguay (0.8) and Colombia (1.35). Age-adjusted (5-34) rates were higher in Costa Rica (1.38) and lower in Chile (0.28). Regarding sex, the analysis of the information provided by seven countries showed a predominance of females (51.8%) over males (48.18%). In the southern Latin American countries such as Chile, Uruguay, Paraguay and Argentina, which have marked climatic differences, deaths occurred mainly in the winter. It is important to emphasize that, in most countries, deaths from asthma occurred at home: Chile (60.7%), Argentina (63.4%) and Paraguay (88%). However, in Uruguay, 58.6% occurred during hospitalization. Mortality rates from bronchial asthma are high in most of the Latin American countries studied, even though further studies are needed. Asthma is a serious global health problem. People of all ages in countries throughout the world are affected by this chronic airway disorder that can be severe and sometimes fatal. The health ministries of each country do not believe asthma is a significant issue. Therefore, we should provide them with sound epidemiological studies to convince them to change their attitude toward this disease.

Entities:  

Mesh:

Year:  1997        PMID: 9330190

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  7 in total

1.  Case-control study of severe life threatening asthma (SLTA) in a developing community.

Authors:  L van der Merwe; A de Klerk; M Kidd; P G Bardin; E M van Schalkwyk
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 2.  Asthma in Hispanics.

Authors:  Gary M Hunninghake; Scott T Weiss; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

Review 3.  Influence of poverty and infection on asthma in Latin America.

Authors:  Philip J Cooper; Laura C Rodrigues; Mauricio L Barreto
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-04

4.  Level of asthma control and its relationship with medication use in asthma patients in Brazil.

Authors:  Josiane Marchioro; Mariana Rodrigues Gazzotti; Oliver Augusto Nascimento; Federico Montealegre; James Fish; José Roberto Jardim
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

Review 5.  Asthma: epidemiology of disease control in Latin America - short review.

Authors:  Dirceu Solé; Carolina Sanchez Aranda; Gustavo Falbo Wandalsen
Journal:  Asthma Res Pract       Date:  2017-05-11

6.  Trends in hospital admissions and mortality rates for asthma in Ecuador: a joinpoint regression analysis of data from 2000 to 2018.

Authors:  Angelita Cabrera; Alejandro Rodriguez; Natalia Romero-Sandoval; Sergio Barba; Philip J Cooper
Journal:  BMJ Open Respir Res       Date:  2021-04

7.  "Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study".

Authors:  Jose Gregorio Soto-Campos; Vicente Plaza; Joan B Soriano; Carlos Cabrera-López; Carlos Almonacid-Sánchez; Rosa Vazquez-Oliva; Jose Serrano; Aitor Ballaz-Quincoces; Alicia Padilla-Galo; Vanessa Santos
Journal:  BMC Pulm Med       Date:  2013-12-10       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.